A study of nearly 60,000 French women found that beta-carotene intake was inversely associated with tobacco-related cancer risk in never-smokers, but increased the risk in former and current smokers. The researchers also calculated that the absolute rates of tobacco-related cancers over 10 years varied significantly between nonsmoking ...
SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateSep 20, 2005
A Phase II study found erlotinib to be relatively well-tolerated and demonstrated encouraging activity in previously untreated patients 70 years or older with advanced lung cancer. The study showed a median survival of 46 weeks, with 60% of patients experiencing partial response or stable disease.
Researchers discovered that compounds from cruciferous veggies can slow down benign to malignant tumors in mice, suggesting potential protection against lung cancer development. The studies also found that these compounds can push human lung cells to commit 'suicide', stopping fast-growing cancer cells.
SourceGeorgetown University Medical Center·JournalCancer Research·DateSep 15, 2005
Researchers at UT Southwestern Medical Center found a compound called GRN163L that blocks the enzyme telomerase, which keeps cells immortal and implicated in most human cancers. The compound works rapidly and in doses considered reasonable for therapy.
SourceUT Southwestern Medical Center·JournalCancer Research·DateSep 1, 2005
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
Researchers at Thomas Jefferson University found that giving chemotherapy and radiation together from the start may help patients with locally advanced lung cancer live longer. The study compared three treatment approaches and showed that combining chemotherapy and radiation improved patient outcomes.
SourceThomas Jefferson University·JournalJournal of Clinical Oncology·DateSep 1, 2005
Research finds that neutropenia, a type of hematological toxicity, is associated with increased overall survival in patients with advanced non-small cell lung cancer. Prospective trials are needed to assess whether drug dosing guided by toxic effects could improve chemotherapy efficacy.
SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateAug 30, 2005
Researchers explore specific tobacco cancer biochemistry and epidemiology, shedding light on why some smokers develop lung cancer while others do not. Key findings include the role of polycyclic aromatic hydrocarbons in forming lesions that lead to gene mutations.
A study published in JAMA Network found that a diagnostic strategy combining Transesophageal ultrasound-guided fine needle aspiration (EUS-FNA) and mediastinoscopy can identify more patients with tumor invasion or lymph node metastases, reducing unnecessary thoracotomies by 16%.
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
Researchers found that gefitinib (Iressa) was significantly effective in treating lung cancer cells containing a mutant EGFR molecule, while cetuximab (Erbitux) had little effect. The study suggests that mutations in the targets of designer drugs critically influence their effectiveness.
SourceDana-Farber Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateAug 16, 2005
Researchers found that gefitinib was more effective at inhibiting cell growth and increasing apoptosis in NSCLC cells with mutant EGFR. In contrast, cetuximab showed no significant response in patients with EGFR mutations.
SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateAug 16, 2005
Scientists at Ohio State University created a mouse model of lung cancer that loses the FHIT gene's protein early in development, leading to larger and more numerous tumors. The study suggests that even low levels of the protein might prevent lung cancer.
SourceOhio State University·JournalCancer Research·DateAug 1, 2005
Apple Watch Series 11 (GPS, 46mm)
Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.
Researchers design dual-chamber nanocell to deliver anti-angiogenic and chemotherapy drugs to tumors, reducing toxicity and improving survival rates. The new approach shows great potential in treating two types of cancers, with mice surviving up to 65 days without severe side effects.
SourceMassachusetts Institute of Technology·JournalNature·DateJul 27, 2005
Researchers found that PGE2 up-regulates T-regulatory cells, suppressing immune function and fueling cancer growth. The study suggests using COX-2 inhibitors like Celebrex to augment immune responses in cancer patients.
SourceUniversity of California - Los Angeles·JournalThe Journal of Immunology·DateJul 15, 2005
A trial involving 731 patients found that treatment with erlotinib resulted in longer survival compared to a placebo, with patients on erlotinib surviving an average of 6.7 months versus 4.7 months. Erlotinib was also well-tolerated and improved physical function, quality of life, and symptoms.
SourceUniversity of Toronto·JournalNew England Journal of Medicine·DateJul 13, 2005
A new report by the European Society for Medical Oncology reveals that female lung cancer death rates in Europe are still rising, despite a 16% increase between 1990-2001. However, trends in some countries and among younger women show a decline, suggesting future hope for reducing this epidemic.
SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·DateJul 12, 2005
Researchers at Dana-Farber Cancer Institute have identified regions of irregular gene copy numbers in non-small cell lung cancer cells, pointing to a large number of previously unknown cancer-causing genes. The study also found that certain genes, including p63, play a role in the development of squamous cell carcinomas.
SourceDana-Farber Cancer Institute·JournalProceedings of the National Academy of Sciences·DateJun 27, 2005
Meta Quest 3 512GB
Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.
A new study finds that post-surgical chemotherapy significantly improves five-year survival rates for patients with non-small cell lung cancer, reducing cancer recurrence by 49% compared to surgery alone. The treatment is inexpensive and has limited side effects, paving the way for a new standard of care.
SourceUniversity of Alberta·JournalNew England Journal of Medicine·DateJun 22, 2005
Christine Chung, a Vanderbilt researcher, has won the Damon Runyon Research Foundation/Lilly Clinical Investigator Award to support her work on genetic profiling for head and neck cancers. The award will provide funding for DNA microarray technology to predict tumor recurrence and response to chemotherapies.
A study found that relatives of black patients with early-onset lung cancer had a risk of developing lung cancer that was more than twice as high as those of white patients. Smokers with a family history of early-onset lung cancer also faced an increased risk, especially after age 60.
Apple MacBook Pro 14-inch (M4 Pro)
Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.
Researchers at NIST have developed a new DNA sequencing chip that detects mtDNA changes associated with early cancer. The chip promises faster, easier interpretation, and higher throughput than current methods, potentially revolutionizing early clinical cancer diagnosis.
SourceNational Institute of Standards and Technology (NIST)·JournalJournal of Molecular Diagnostics·DateJun 16, 2005
Researchers at UNC Chapel Hill found that radiation exposure at older ages significantly increases the risk of lung cancer among Hanford nuclear workers. The study analyzed data from 26,389 workers hired between 1944 and 1978 and identified 2,265 cancer deaths.
SourceUniversity of North Carolina at Chapel Hill·JournalOccupational and Environmental Medicine·DateJun 16, 2005
A new study finds that tobacco smoke exposure is responsible for most premature cancer deaths among African-American males, with Southern and Midwestern states showing greater burdens due to weaker tobacco control policies. The study suggests that strengthening tobacco control measures can help reduce these deaths.
SourceUniversity of California - Davis Health·JournalPreventive Medicine·DateJun 13, 2005
Apple AirPods Pro (2nd Generation, USB-C)
Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.
A study of young adults found a strong association between asthma and panic disorder, with active asthma predicting subsequent panic disorder. The 'electronic nose' technology also showed promise in detecting lung cancer by analyzing exhaled breath samples.
SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJun 1, 2005
A landmark Phase III trial found that concurrent chemotherapy and radiation therapy followed by surgery significantly improves lung cancer patient survival. Five-year survival rates were 36% for patients with partial lung removal and 27% for those who underwent concurrent treatment.
A national population-based study of 16,036 lung cancer patients found that Hispanics with curable stage I lung cancer had poorer lung cancer specific survival rates and worse all-cause mortality than white persons. This disparity was largely explained by lower surgical resection rates among Hispanics and a higher probability of being ...
SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateMay 16, 2005
A study by the University of California - Davis Health has demonstrated a significantly improved survival rate for locally advanced lung cancer patients using a chemotherapy regimen that includes docetaxel. The study showed a five-year survival rate of 29 percent, surpassing previous results.
SourceUniversity of California - Davis Health·DateMay 16, 2005
Fluke 87V Industrial Digital Multimeter
Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.
A recent Mount Sinai study found that Hispanic patients with stage I non-small cell lung cancer have a significantly lower five-year survival rate of 54% compared to white patients at 62%. This disparity is largely attributed to unequal access to surgical resection, as well as higher rates of advanced-stage diagnosis.
SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateMay 15, 2005
The Lancet suggests that aggressive tobacco taxation policies are needed to reduce the demand for tobacco products, which cause 5 million deaths annually. Annual price increases of 50% can lead to a reduction in tobacco consumption by 4-8% in high-income and low-middle income countries, respectively.
Researchers found that advanced NSCLC patients with high EGFR gene copy number, protein expression, or mutations respond better to gefitinib. High EGFR gene copy number is associated with prolonged survival and disease control.
SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateMay 3, 2005
A new study found that increasing Pap screening adherence and improving its accuracy could reduce the incidence of invasive cervical cancer among women with access to screening. The study also identified factors associated with screening failure, including lack of Pap testing and unrelated outpatient visits.
SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateMay 3, 2005
AmScope B120C-5M Compound Microscope
AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.
Researchers have developed a new technology that uses DNA methylation profiling to detect cells in the lung likely to become cancerous. The method combines high-powered microscopes with the capability of analyzing many samples at a time, providing a breakthrough in identifying high-risk individuals.
Research investigates associations between male breast cancer, human papillomavirus (HPV) infections, and genetic variants in DNA repair genes. Ionizing radiation exposure is linked to higher male breast cancer incidence among atomic bomb survivors, while HPV detection is strongly associated with HIV status. Genetic polymorphisms in DN...
SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateApr 19, 2005
University scientists have discovered ways to detect areas of instability in DNA that can lead to cancer. By applying this technology to pre-cancerous lesions, they've found that DNA damage occurs very early in the carcinogenic process, highlighting those at risk of developing cancer.
SourceUniversity of Liverpool·JournalNature·DateApr 14, 2005
Researchers found that smokers receiving multiple abnormal CT scans were more likely to quit smoking and remain smoke-free. The study suggests that abnormal lung cancer screening results can serve as a psychological push for smokers to quit, leading to increased success rates.
Nikon Monarch 5 8x42 Binoculars
Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.
The American Cancer Society no longer recommends testing for early lung cancer detection, citing reduced risks after quitting smoking. However, a new position statement strongly advocates for asymptomatic screening in clinical trials or informed discussion of options.
Researchers are developing a vaccine using dendritic cells to boost the immune system against lung cancer recurrence. The study enrolls patients for two years, with promising previous results, aiming to treat 30 new patients.
A recent study suggests that CT lung cancer screening may not be as beneficial as previously thought, as many early-stage cancers detected through CT are slow-growing and unlikely to have been fatal. The study found that unnecessary surgical procedures and expenses were also significant drawbacks.
SourceRadiological Society of North America·JournalRadiology·DateMar 24, 2005
Researchers at Yale University have discovered that the microRNA let-7 regulates the Ras cancer gene by binding to its mRNA and inhibiting translation. This finding has significant implications for understanding cancer progression and developing new treatments, including gene therapy with let-7.
A recent multi-center study found a direct link between residential radon exposure and increased lung cancer risk, with risks estimated to be 11-21% higher than average levels. The study, pooling data from seven North American studies, supports earlier findings and provides unambiguous evidence of the association.
SourceUniversity of Iowa·JournalEpidemiology·DateMar 14, 2005
Aranet4 Home CO2 Monitor
Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.
Mutations in the EGFR gene are more common in people with lung cancer who never smoked, and these mutations may predict a dramatic response to certain drugs. The study's findings suggest two distinct molecular pathways involved in lung cancer formation, one affecting smokers and the other non-smokers.
SourceUT Southwestern Medical Center·JournalJNCI Journal of the National Cancer Institute·DateMar 1, 2005
A recent study found that epidermal growth factor receptor (EGFR) gene mutations are more common in never smokers, females, and patients of East Asian ancestry. The mutations were also associated with increased sensitivity to gefitinib and erlotinib, tyrosine kinase inhibitors.
SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateMar 1, 2005
Researchers at UT Southwestern will investigate the consequences of space radiation exposure on human health, with a focus on lung cancer and its prevention. The $9.8 million grant will enable the development of new cell systems and animal models to study high-energy particles in space.
A recent study reveals that cancer cells can develop resistance to gefitinib by mutating the EGFR gene, altering the drug's binding pocket and rendering it ineffective. This finding could lead to the development of new targeted therapies to treat non-small cell lung cancer.
SourceBeth Israel Deaconess Medical Center·JournalNew England Journal of Medicine·DateFeb 23, 2005
Researchers found that tumors developing secondary resistance to Tarceva and Iressa had an additional EGFR mutation, rendering the drugs ineffective. The discovery highlights the need for alternative targeted therapies for patients with KRAS mutations.
SourceMemorial Sloan Kettering Cancer Center·JournalPLOS Medicine·DateFeb 21, 2005
Apple iPad Pro 11-inch (M4)
Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.
Scientists found that tumors from six patients with non-small cell lung cancer who initially responded to gefitinib or erlotinib but relapsed carried activating mutations in the EGFR gene. The resistant tumor cells also carried a second mutation in the EGFR gene, which causes resistance to these drugs.
The report reveals that nearly 2.9 million new cases of cancer were diagnosed in Europe in 2004, with lung cancer being the most common form. Breast cancer is also on the rise, while stomach cancer rates are falling. The study emphasizes the need for a joint European effort to combat these diseases.
SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·DateFeb 16, 2005
New studies suggest that blocking estrogen may be essential to slowing the spread of lung cancer. Researchers found that a combination therapy targeting both estrogen and epidermal growth factor receptors resulted in a 59% tumor volume decrease.
SourceUniversity of Pittsburgh Medical Center·JournalCancer Research·DateFeb 15, 2005
A new study published in PLOS Medicine found that patients with KRAS mutations do not respond to targeted therapy drugs erlotinib and gefitinib. Analyzing tumors for EGF receptor and KRAS mutations may be crucial to predicting treatment effectiveness.
A study examining genetic factors in lung cancer found increased risks for first-, second-, and third-degree relatives of patients with lung cancer. The risk was stronger for early-onset disease, suggesting a possible genetic component beyond environmental factors.
Sky-Watcher EQ6-R Pro Equatorial Mount
Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.
A study of 10,591 Taiwanese residents found that those exposed to high levels of arsenic in their drinking water had a 3.29 times increased risk of developing lung cancer. Cigarette smoking further exacerbated this risk, particularly among non-smokers and those with lower arsenic exposure.
Researchers studied 155 image-guided RFA lung procedures on 126 medically inoperable patients with 163 lesions, finding low complication rates and improved morbidity. The outpatient procedure effectively controls small tumors, allowing patients to avoid surgery and improve their quality of life.
SourceRadiological Society of North America·DateDec 1, 2004
A long-term study found that women had a higher risk of death from cardiovascular disease and lung cancer after stopping beta-carotene supplements, while the excess risk in men disappeared. The results suggest careful monitoring is needed to document long-term safety and efficacy.
SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateNov 30, 2004
A new study of pesticide applicators found an increased incidence of lung cancer associated with chlorpyrifos exposure. Meanwhile, research on celecoxib-induced apoptosis in human lung cancer cells and the molecular mechanism of DNA repair proteins' relation to malignant melanoma are also reported.
SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateNov 30, 2004
Sky & Telescope Pocket Sky Atlas, 2nd Edition
Sky & Telescope Pocket Sky Atlas, 2nd Edition is a durable star atlas for planning sessions, identifying targets, and teaching celestial navigation.
A new study found that smokers who start screening at age 50 or older have a risk for developing lung cancer similar to those who smoked heavily for many years. Annual CT screening can identify high percentages of Stage I diagnoses, the most curable form of lung cancer.
SourceRadiological Society of North America·DateNov 29, 2004
A recent pilot study found that only a minority of subjects received a diagnostic work-up according to published algorithms, and that larger nodule sizes were associated with lower use of biopsy for follow-up. Only 7% of subjects diagnosed with lung cancer within a year of the first positive screen.
Researchers at Ohio State University have identified a new protein, Pirh2, that diminishes the activity of p53, a powerful tumor suppressor. Overexpression of Pirh2 was found in 84% of human lung cancers and 93% of mouse tumors, suggesting its potential role in cancer development.
SourceOhio State University·JournalJNCI Journal of the National Cancer Institute·DateNov 16, 2004
GoPro HERO13 Black
GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.
The Weizmann Institute will receive a $8 million grant from FAMRI to focus on lung cancer research related to second-hand and mainstream tobacco smoke. Researchers from the institute and Sheba Medical Center will collaborate to advance treatment protocols.
SourceAmerican Committee for the Weizmann Institute of Science·DateNov 9, 2004
Researchers are exploring the potential of tomato oil to reverse or delay progression of high-grade prostatic intraepithelial neoplasia (HGPIN), a precursor to prostate cancer. The study, led by Dr. Peter Gann, aims to clarify lycopene's mechanisms in the prostate and determine its chemopreventive potential.
The study found that silencing of the PTPRO gene causes a drop in the level of the enzyme, leading to increased cell proliferation and cancer development. Over-producing the PTPRO enzyme slowed the growth of cancer cells and induced programmed cell death.
SourceOhio State University·JournalProceedings of the National Academy of Sciences·DateNov 4, 2004
Researchers found that a combination of two novel agents - SCH66336 and IGFBP-3 - significantly reduced lung tumor size in mice implanted with human lung tumors. The treatment blocked multiple pathways important to cancer cell survival, showing tremendous potential for treating lung cancer patients.
SourceUniversity of Texas M. D. Anderson Cancer Center·JournalJNCI Journal of the National Cancer Institute·DateOct 19, 2004